Abstract
AMONG the degenerative diseases of the nervous system of metabolic origin, there is a group of conditions in which substances accumulate to excess within neurons. In some of these processes, the nature of the stored material has been well characterized. In Tay-Sachs disease, the accumulation of a particular ganglioside is well-documented. Recently, there have been suggestions about the nature of the enzymatic defect; for example, the dysfunction of a catabolic enzyme, a lipid hexoseaminidase 1 (oral communication, with L. Svennerholm, MD, May 1968). In other diseases, the fact that there is storage of some material is well-documented, but the composition of the stored material and the nature of the metabolic defect is not known. An example of this type of disease is the late infantile form of neuronal storage disease. The study of the neuronal storage diseases is handicapped by the fact that not all cells show the storage
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.